HOME › DRUGS › LENVATINIB
ACTIVE SUBSTANCE / INN

LENVATINIB

Brand name(s): Lenvima, Kisplyx
EMA LISTED
AUTHORISED
Carcinoma, Renal Cell
Thyroid Neoplasms
ACTIVE SUBSTANCE
Lenvatinib
REGULATORS
EMA
SPONSORS / MAH
Eisai GmbH
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LenvimaEisai GmbHAuthorised28/05/2015Thyroid Neoplasms
KisplyxEisai GmbHAuthorised25/08/2016Carcinoma, Renal Cell

FULL INTELLIGENCE ON LENVATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →